Mireille Van Gele

3.9k total citations
65 papers, 2.7k citations indexed

About

Mireille Van Gele is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mireille Van Gele has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Immunology. Recurrent topics in Mireille Van Gele's work include Neuroblastoma Research and Treatments (10 papers), RNA Interference and Gene Delivery (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Mireille Van Gele is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), RNA Interference and Gene Delivery (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Mireille Van Gele collaborates with scholars based in Belgium, Netherlands and United States. Mireille Van Gele's co-authors include Jo Lambert, Reinhart Speeckaert, Frank Speleman, Nadine Van Roy, Liève Brochez, Eline Desmet, Peter Dynoodt, Nanja van Geel, Barbara Geusens and J. Helen Leonard and has published in prestigious journals such as Genes & Development, Blood and PLoS ONE.

In The Last Decade

Mireille Van Gele

65 papers receiving 2.6k citations

Peers

Countries citing papers authored by Mireille Van Gele

Since Specialization

Citations

This map shows the geographic impact of Mireille Van Gele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille Van Gele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille Van Gele more than expected).

Fields of papers citing papers by Mireille Van Gele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille Van Gele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille Van Gele. The network helps show where Mireille Van Gele may publish in the future.

Co-authorship network of co-authors of Mireille Van Gele

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille Van Gele. A scholar is included among the top collaborators of Mireille Van Gele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille Van Gele. Mireille Van Gele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response 2017 ·Journal of Translational Medicine ·Nora Sundahl, Katrien De Wolf, Sylvie Rottey, Karel Decaestecker, Daan De Maeseneer, Annabel Meireson, Els Goetghebeur, Valérie Fonteyne, Sofie Verbeke, Pieter De Visschere, Dries Reynders, Mireille Van Gele, Liève Brochez, Piet Ost	26
2	Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate to severe psoriasis 2016 ·European Journal of Dermatology ·Mireille Van Gele, Stefanie Bracke, (unknown), Jo Lambert	6
3	Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma 2015 ·Journal of Translational Medicine ·Inès Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko, Claus Bachert, Mireille Van Gele, Nanja van Geel, Liève Brochez	52
4	Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma 2015 ·OncoImmunology ·Inès Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko, Claus Bachert, Benjamin Hennart, Delphine Allorge, Nanja van Geel, Mireille Van Gele, Liève Brochez	92
5	Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model 2013 ·Archives of Dermatological Research ·Stefanie Bracke, Eline Desmet, Sara Guerrero‐Aspizua, (unknown), Joost Schalkwijk, Mireille Van Gele, Marta Carretero, Jo Lambert	32
6	Immune mediated mechanisms of melanocyte destruction 2012 ·OncoImmunology ·Reinhart Speeckaert, Nanja van Geel, Jo Lambert, Barbara Boone, Inès Chevolet, Mireille Van Gele, Marijn M. Speeckaert, Liève Brochez	4
7	Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations 2011 ·Expert Opinion on Drug Delivery ·Mireille Van Gele, Barbara Geusens, Liève Brochez, Reinhart Speeckaert, Jo Lambert	70
8	The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562 2010 ·Molecular Nutrition & Food Research ·(unknown), Barbara Vanhoecke, Mireille Van Gele, Jan Philippé, Marc Bracke, Fritz Offner	19
9	P-cadherin counteracts myosin II-B function: implications in melanoma progression 2010 ·Molecular Cancer ·(unknown), Mireille Van Gele, Ramses Forsyth, Liève Brochez, Barbara Vanhoecke, Olivier De Wever, Marc Bracke	18
10	Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia 2009 ·Leukemia Research ·Jerina Boelens, Sofie Lust, Femke Van Bockstaele, Mireille Van Gele, Ann Janssens, Lara Derycke, Barbara Vanhoecke, Jan Philippé, Marc Bracke, Fritz Offner	13
11	Griscelli syndrome: a model system to study vesicular trafficking 2009 ·Pigment Cell & Melanoma Research ·Mireille Van Gele, Peter Dynoodt, Jo Lambert	123
12	Knockdown of Myosin Va Isoforms by RNAi as a Tool to Block Melanosome Transport in Primary Human Melanocytes 2008 ·Journal of Investigative Dermatology ·Mireille Van Gele, Barbara Geusens, Anne-Marie Schmitt, Luc Aguilar, Jo Lambert	30
13	Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma (vol 101, pg 103, 2002) 2004 ·Ghent University Academic Bibliography (Ghent University) ·J. Helen Leonard, Anthony L. Cook, Mireille Van Gele, (unknown), (unknown), Frank Speleman, Richard A. Sturm	3
14	Combined karyotyping, CGH and M‐FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma 2002 ·International Journal of Cancer ·Mireille Van Gele, J. Helen Leonard, Nadine Van Roy, Heidi Van Limbergen, Simon Van Belle, Véronique Cocquyt, Helen R. Salwen, Anne De Paepe, Frank Speleman	65
15	Frequent allelic loss at 10q23 but low incidence ofPTEN mutations in merkel cell carcinoma 2001 ·International Journal of Cancer ·Mireille Van Gele, J. Helen Leonard, Nadine Van Roy, Anthony L. Cook, (unknown), Frank Speleman	46
16	Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein–methyltransferase superfamily 2001 ·Genes & Development ·George Steele-Perkins, Wei Fang, (unknown), Mireille Van Gele, Tobias Carling, Jian Gu, I. Buyse, (unknown), Jinsong Liu, Roderick T. Bronson, Robert B. Chadwick, Albert de la Chapelle, Xiao-kun Zhang, Frank Speleman, Shi Huang	164
17	Chromosome 2 short arm translocations revealed by M-FISH analysis of neuroblastoma cell lines 2000 ·Medical and Pediatric Oncology ·Nadine Van Roy, Heidi Van Limbergen, Jo Vandesompele, Mireille Van Gele, Bruce Poppe, Geneviève Laureys, (unknown), Frank Speleman	14
18	Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes 1997 ·European Journal of Cancer ·Nadine Van Roy, Geneviève Laureys, Mireille Van Gele, Ghislain Opdenakker, R. Miura, (unknown), Alvin Chan, Rogier Versteeg, Frank Speleman	30
19	Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines 1997 ·Cancer Genetics and Cytogenetics ·Nadine Van Roy, Anna Jauch, Mireille Van Gele, Geneviève Laureys, Rogier Versteeg, Anne De Paepe, Thomas Cremer, Frank Speleman	38
20	Improved protocol for the preparation of chromatin fibres from fixed cells 1997 ·Frank Speleman, Mireille Van Gele, Luc Maertens, Nadine Van Roy	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact